HomeNDC LookupRxCUI directory › RxCUI 992675

Homatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML Oral Solution [Hydrom... — RxCUI 992675

RxNorm drug concept · Semantic branded drug
RxCUI 992675 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI992675
Official nameHomatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML Oral Solution [Hydromet]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHydromet (homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG) per 5 ML Syrup; Hydromet 5 MG / 1.5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)1,070 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocodone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This extended-release form of hydrocodone is designed for pain that is severe and present all day, every day — the kind that needs steady, around-the-clock control rather than occa...
  • Why did my doctor prescribe this instead of a regular pain pill?
  • Absolutely not — and this is one of the most important things to know. These products are engineered to release hydrocodone slowly over many hours. If you crush, chew, break, or di...
  • Can I crush or cut the tablet or capsule to make it easier to swallow?
📖 Read our full Hydrocodone guide →

🕸️ Concept Web — How Homatropine methylbromide 0.3 MG/ML / hydrocodon... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Homatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML Oral Solution [Hydromet] RxCUI 992675

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Homatropine 27084
    • Hydrocodone 5489
    • Homatropine / hydrocodone 214614
    • Homatropine methylbromide 27085
    • Hydrocodone bitartrate 142439
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hydromet 151875
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Homatropine / hydrocodone Oral Solution 757041
    • Homatropine methylbromide / hydrocodone bitartrate Oral Solution 2648332
    • Homatropine / hydrocodone Oral Liquid Product 1159519
    • Homatropine / hydrocodone Oral Product 1159520
    • Homatropine methylbromide / hydrocodone bitartrate Oral Liquid Product 2659184
    • Homatropine methylbromide / hydrocodone bitartrate Oral Product 2659868
    • Homatropine / hydrocodone Oral Solution [Hydromet] 757043
    • Homatropine methylbromide / hydrocodone bitartrate Oral Solution [Hydromet] 2657128
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Homatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML Oral Solution SCD · 992668
  • Homatropine methylbromide 0.3 MG/ML SCDC · 992667
  • Hydrocodone bitartrate 1 MG/ML SCDC · 856914
  • Homatropine / hydrocodone Oral Solution SCDF · 757041
  • Homatropine methylbromide / hydrocodone bitartrate Oral Solution SCDFP · 2648332
  • Homatropine / hydrocodone Oral Liquid Product SCDG · 1159519
  • Homatropine / hydrocodone Oral Product SCDG · 1159520
  • Homatropine methylbromide / hydrocodone bitartrate Oral Liquid Product SCDGP · 2659184
  • Homatropine methylbromide / hydrocodone bitartrate Oral Product SCDGP · 2659868

Brand-Name Concepts

  • Homatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML [Hydromet] SBDC · 992674
  • Homatropine / hydrocodone Oral Solution [Hydromet] SBDF · 757043
  • Homatropine methylbromide / hydrocodone bitartrate Oral Solution [Hydromet] SBDFP · 2657128
  • Hydromet Oral Liquid Product SBDG · 1175452
  • Hydromet Oral Product SBDG · 1175453
  • Hydromet BN · 151875

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 992675 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00472-1030-16 473 mL in 1 BOTTLE (0472-1030-16) Hydromet Actavis Pharma, Inc. 2002-09-30
Observed labelers: Actavis Pharma, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1005
Range $0.1005–$0.1005 · middle 50% $0.1005–$0.1005 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.